Should You Avoid Impax Laboratories Inc (IPXL)?
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Impax Laboratories Llc (IPXL)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | Engineers Gate Manager Greg Eisner | 0 | $0 | 0% | |
| 3. | Paloma Partners Donald Sussman | 0 | $0 | 0% | |
| 4. | Element Capital Management Jeffrey Talpins | 0 | $0 | 0% | |
| 5. | Winton Capital Management David Harding | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.73 | 1,000 | Officer | 36,916 | 2013-03-12 | Filing | |
| $16.88 | 7,000 | Officer, Director | 2,309,908 | 2013-03-12 | Filing | |
| $16.72 | 500 | Director | 6,700 | 2013-03-12 | Filing | |
| $19.00 | 10,000 | Officer, Director | 426,903 | 2011-08-16 | Filing | |
| $15.71 | 500 | Director | 4,500 | 2011-08-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.00 | 1,130 | Officer | 106,943 | 2017-05-31 | Filing | |
| $16.48 | 857 | Officer | 108,073 | 2017-05-17 | Filing | |
| $17.11 | 700 | Officer | 115,168 | 2017-05-12 | Filing | |
| $22.81 | 10,092 | Director | 30,133 | 2016-08-15 | Filing | |
| $43.56 | 5,000 | Officer | 111,833 | 2015-09-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | Fmr LlcBOND | 0 | $0 | 0% |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Why CarMax, Teva Pharmaceuticals And Three Other Stocks Are in Spotlight on Tuesday
Crude prices are 1.5% lower today as traders are taking profits on yesterday's run-up.
Kyle Bass Slashes Portfolio to Short the Yuan
Kyle Bass of Hayman Capital, widely known for betting against subprime mortgages and earning hundreds of millions of dollars from that bet, is making another bold prediction, this time about the world...
The Latest Moves by Hedge Funds on 3 Conviction Stocks
Hedge fund vehicles have been underperforming the broader market since 2009, but their investors didn’t necessarily expect them to beat benchmarks.
Do Hedge Funds Love Impax Laboratories Inc (IPXL)?
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings.
New Additions Highlight Kyle Bass' Top Stock Picks for Q4
Kyle Bass of Hayman Advisors is one investment manager with great cachet, which includes having a chapter dedicated to him in Michael Lewis' post 2007-08 financial crises book 'Boomerang'.
Why Are These Four Stocks Gaining Ground on Monday?
The major indices have lost over 1% so far on Monday, but several stocks are making big moves in the opposite direction, registering significant gains fueled by positive developments.
Major Insider Activity Spotted At Inovalon Holdings Inc. (INOV), Impax Laboratories Inc. (IPXL), and Integrated Silicon Solution Inc. (ISSI)
Generally, insider buying is believed to suggest management’s confidence in the company and its future outlook, whereas insider selling is usually seen as a bearish sign (however, insider selling may...
Apple (AAPL) Holding Slashed By Giovine Capital But Remains Fund's Top Pick For Q3
Giovine Capital is a hedge fund that was founded in 1998 by Thomas A. Giovine, who is also the current manager.
Top New Picks of Healthcare Fund Blue Jay Capital: Endo International plc (ENDP), Alkermes Plc (ALKS), Akorn Inc. (AKRX)
Healthcare-focused fund Blue Jay Capital Management, managed by Paul Sinclair, has disclosed its equity portfolio for the reporting period of March 31 in a 13F filed with the U.S.
Billionaire Hedge Funds
